有色皮肤患者皮肤t细胞淋巴瘤的免疫发病机制第一部分:蕈样真菌病

Sachi I. Desse , Nina C. Nwade , Akanksha Nagarkar , Nia E.R. James , Ryan Svoboda , Ginette A. Okoye , Angel S. Byrd , Jillian M. Richmond
{"title":"有色皮肤患者皮肤t细胞淋巴瘤的免疫发病机制第一部分:蕈样真菌病","authors":"Sachi I. Desse ,&nbsp;Nina C. Nwade ,&nbsp;Akanksha Nagarkar ,&nbsp;Nia E.R. James ,&nbsp;Ryan Svoboda ,&nbsp;Ginette A. Okoye ,&nbsp;Angel S. Byrd ,&nbsp;Jillian M. Richmond","doi":"10.1016/j.clicom.2023.07.004","DOIUrl":null,"url":null,"abstract":"<div><p>Mycosis fungoides (MF) is the most common subtype of Cutaneous T-Cell Lymphoma (CTCL). Patients with Skin of Color (SOC) may be disproportionately impacted by MF due to delayed diagnoses, limited research, and treatment differences. In this graphical review, we provide an overview of MF immunopathogenesis and demonstrate how it manifests differently in SOC patients. We also provide our hypothesis for why the disease process can result in a myriad of clinical presentations in SOC patients. Last, we provide a summary of current treatment options, highlighting ongoing clinical trials and opportunities to include SOC patients to promote health equity.</p></div>","PeriodicalId":100269,"journal":{"name":"Clinical Immunology Communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunopathogenesis of cutaneous T-cell lymphoma in skin of color patients part 1: Mycosis fungoides\",\"authors\":\"Sachi I. Desse ,&nbsp;Nina C. Nwade ,&nbsp;Akanksha Nagarkar ,&nbsp;Nia E.R. James ,&nbsp;Ryan Svoboda ,&nbsp;Ginette A. Okoye ,&nbsp;Angel S. Byrd ,&nbsp;Jillian M. Richmond\",\"doi\":\"10.1016/j.clicom.2023.07.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Mycosis fungoides (MF) is the most common subtype of Cutaneous T-Cell Lymphoma (CTCL). Patients with Skin of Color (SOC) may be disproportionately impacted by MF due to delayed diagnoses, limited research, and treatment differences. In this graphical review, we provide an overview of MF immunopathogenesis and demonstrate how it manifests differently in SOC patients. We also provide our hypothesis for why the disease process can result in a myriad of clinical presentations in SOC patients. Last, we provide a summary of current treatment options, highlighting ongoing clinical trials and opportunities to include SOC patients to promote health equity.</p></div>\",\"PeriodicalId\":100269,\"journal\":{\"name\":\"Clinical Immunology Communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Immunology Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772613423000173\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772613423000173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

蕈样肉芽肿(MF)是皮肤T细胞淋巴瘤(CTCL)最常见的亚型。由于诊断延迟、研究有限和治疗差异,有色人种皮肤(SOC)患者可能会受到MF的不成比例的影响。在这篇图表综述中,我们概述了MF的免疫发病机制,并证明了它在SOC患者中的不同表现。我们还提供了我们的假设,说明为什么疾病过程会导致SOC患者出现无数临床表现。最后,我们总结了当前的治疗方案,强调了正在进行的临床试验和纳入SOC患者以促进健康公平的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Immunopathogenesis of cutaneous T-cell lymphoma in skin of color patients part 1: Mycosis fungoides

Mycosis fungoides (MF) is the most common subtype of Cutaneous T-Cell Lymphoma (CTCL). Patients with Skin of Color (SOC) may be disproportionately impacted by MF due to delayed diagnoses, limited research, and treatment differences. In this graphical review, we provide an overview of MF immunopathogenesis and demonstrate how it manifests differently in SOC patients. We also provide our hypothesis for why the disease process can result in a myriad of clinical presentations in SOC patients. Last, we provide a summary of current treatment options, highlighting ongoing clinical trials and opportunities to include SOC patients to promote health equity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信